-
Qigesan inhibits migration and invasion of esophageal cancer cells via inducing connexin expression and enhancing gap junction function
Journal： Cancer Letters
引用产品：anti-Cx26 antibody(BS3443)
ApplicationWB
IF8.679
SpeciesHuman
-
Qigesan inhibits migration and invasion of esophageal cancer cells via inducing connexin expression and enhancing gap junction function
Journal： Cancer Letters
引用产品：anti-Cx43 antibody()
ApplicationWB
IF8.679
SpeciesHuman
-
PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancer
Journal： Cancer Letters
引用产品：anti-mCD4 antibody()
ApplicationIHC
IF8.679
SpeciesMouse
-
ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell
Journal： Cancer Letters
引用产品：anti-Crkl antibody(BS1706)
ApplicationWB
IF8.679
SpeciesHuman
-
ABL SH3 mutant inhibits BCR-ABL activity and increases imatinib sensitivity by targeting RIN1 protein in CML cell
Journal： Cancer Letters
引用产品：anti-p-Crkl antibody(BS4056)
ApplicationWB
IF8.679
SpeciesHuman
-
Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer
Journal： Theranostics
引用产品：anti-VEGF antibody(BS6496)
ApplicationWB
IF8.579
SpeciesHuman
-
c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
Journal： Theranostics
引用产品：anti-pAKT 473 antibody(BS4007)
ApplicationWB
IF8.579
SpeciesHuman
-
c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
Journal： Theranostics
引用产品：anti-AKT antibody(BS1379)
ApplicationWB
IF8.579
SpeciesHuman
-
c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis
Journal： Theranostics
引用产品：anti-GAPDH antibody(AP0063)
ApplicationWB
IF8.579
SpeciesHuman
-
In vivo MR and Fluorescence Dual-modality Imaging of Atherosclerosis Characteristics in Mice Using Profilin-1 Targeted Magnetic Nanoparticles
Journal： Theranostics
引用产品：DAPI(BD5010)
Application
IF8.579
Species
